Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2013

IntelGenx Technology Corp. (IGX) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

IntelGenx Technology is a drug delivery company engaged in developing oral controlled-release products and novel rapidly disintegrating delivery systems. Using its unique multiple layer delivery system, the company provides zero-order release of active drugs in the gastrointestinal tract. The company … Continue reading →

Posted in OneMedForum Conference | Leave a comment

NovaBay Pharmaceuticals Inc. (NBY) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

NovaBay Pharmaceuticals is a clinical-stage biotech company focused on the development of its proprietary and patented Aganocide® compounds. NBY focuses its technology on four therapeutic areas: dermatology, ophthalmology, urology and hospital infections. The company has entered into and recently expanded … Continue reading →

Posted in EBD Group Conference | Leave a comment

BioLife Solutions, Inc. (BLFS) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

BioLife Solutions is a leading developer, manufacturer and marketer of patented hypothermic storage and cryopreservation solutions for cells and tissues. The company markets its proprietary HypoThermosol and CryoStor solutions to academic and commercial organizations involved in cell therapy, tissue engineering, … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Shire (SHPG) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Shire is a biopharmaceutical company that focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medicine as well as opportunities in other therapeutic areas. SHPG’s in-licensing, merger and acquisition efforts are focused on products … Continue reading →

Posted in EBD Group Conference | Leave a comment

Organovo Holdings Inc. (ONVO) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Organovo Holdings focuses on breakthrough 3D biology capabilities to create tissue on-demand for research and surgical applications. The company’s NovoGen MMX Bioprinter™ is the world’s only commercial bioprinter with the proven ability to create tissue. The novel and flexible capabilities … Continue reading →

Posted in EBD Group Conference | Leave a comment

Resverlogix Corp. (RVXCF) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Resverlogix is a clinical stage cardiovascular company with an epigenetic platform technology that modulates protein production. The company is developing RVX-208 for the treatment of atherosclerosis. RVX’s business model is to seek strategic opportunities through early alliance partnerships with the … Continue reading →

Posted in EBD Group Conference | Leave a comment

Amarantus Bioscience, Inc. (AMBS) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

Amarantus Bioscience is a development-stage biotechnology company focused on developing certain biologics surrounding its intellectual property and proprietary technologies for treating and/or diagnosing Parkinson’s disease, traumatic brain injury and other human diseases. Amarantus owns the intellectual property rights to Mesencephalic-Astrocyte-derived … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Oragenics, Inc. (OGEN) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

Oragenics is dedicated to becoming a global leader in probiotics for oral health in humans and pets and in novel antibiotics against infectious disease. The company is engaged in developing, marketing and selling proprietary probiotics under the brand names Evora … Continue reading →

Posted in OneMedForum Conference | Leave a comment

ZBB Energy Corp. (ZBB) Secures Order for Grid Independent ZBB EnerSystem with University of Technology Sydney

Posted on January 8, 2013 by MissionIR

ZBB Energy, the developer of cutting-edge electrical power management platform architectures that fit the growing global need for distributed renewable energy, energy efficiency, power quality, and ultimately grid modernization, reported today that the company has landed an order for one … Continue reading →

Posted in Small Cap News | Leave a comment

NeuroMetrix, Inc. (NURO) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

NeuroMetrix is an innovative medical device company focused on developing and marketing home use and point-of-care devices, associated consumables and support software for treating and managing diabetes and its complications. Nerve-related complications of diabetes, or diabetic neuropathies, affect more than … Continue reading →

Posted in OneMedForum Conference | Leave a comment